UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

Abroad (travel likely)RecruitingPHASE1

Conditions

Systemic Lupus Erythematosus · Lupus Nephritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Contact: Study coordinator (Juan hui Mao) · huijuanmao@126.com

Study leads

Huijuan Mao, Doctor
Principal Investigator
Jiangsu Province Hospital, the First Afﬁliated Hospital of Nanjing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus · Lupus Nephritis (LN) · Sjogren's Syndrome

Abroad (travel likely)RecruitingPHASE1

Bengbu, China

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Lupus Nephritis (LN) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Hefei, China

UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients

SLE · Lupus · Systemic Lupus Erthematosus

Abroad (travel likely)RecruitingPHASE1

Charleston, United States

Biomarker Development for Autoimmune Disorders Involving the Kidneys

Lupus Nephritis · Systemic Lupus Erythematosus

Abroad (travel likely)Recruiting

Oslo, Norway